scispace - formally typeset
Open AccessJournal Article

Long-term survival.

Cho Yw, +1 more
- 01 Jan 1988 - 
- pp 277
TLDR
In transplants performed between 1971 and 1986, first cadaver donor grafts had a half-life ranging from 6.6 to 7.5 years in the period after the first year, and for patients receiving kidneys with no HLA-A,B mismatches, the average half- life was 10.1 years.
Abstract
1. In transplants performed between 1971 and 1986, first cadaver donor grafts had a half-life ranging from 6.6 to 7.5 years in the period after the first year. Second cadaver donor grafts had a half-life of 5.1 to 6.5 years. Parental donor grafts had a half-life of 9.3 to 11.8 years, whereas HLA identical sibling donor transplants had a half-life of 19.1 to 26.5 years. Siblings with no haplotype in common had an average half-life of 8.7 years. 2. Between 1971 and 1984, white recipients had an average half-life of 7.7 years, which increased to 9.3 years in 1985-1986. Black recipients' half-life decreased from 5.4 years in 1975-1976 to 3.5 years in 1985-1986. The reason for this decrease is not apparent. 3. The half-life of transplants of different recipient ages did not vary significantly. The average half-life during this period of study was 7.4 years for those younger than 21 years of age, 8.2 years for recipients 21 to 50 and 6.7 years for those older than 50. 4. In the early data, there was some evidence that the half-life of kidneys with cold ischemia below 13 hours was superior. However, in the latest period (between 1983 and 1986) the average half-life was 7.6 years for CIT below 13 hours, 7.2 years for those with 13 to 24 hours and 6.4 years for more than 24 hours. 5. For patients receiving kidneys with no HLA-A,B mismatches, the average half-life was 10.1 years. Those with A,B mismatches had a half-life of 6.7 years, and for those with no A,B antigens in common, the average half-life was 6 years. 6. In the period after 1981, the average half-life of patients with no A,B,DR mismatches was 9.1 years compared with 6.5 years for those with A,B,DR mismatches and 5.4 years for those with no A,B,DR antigens in common.

read more

Citations
More filters
Journal ArticleDOI

Mortality after traumatic spinal cord injury: 50 years of follow-up

TL;DR: Patients with a TSCI, and especially women, have an increased mortality despite modern treatment and care, and special attention should be paid to respiratory dysfunction and pulmonary infections, and to prevent suicide and accidental poisoning.
Book ChapterDOI

New Immunosuppressive Drugs

R. Kurrle, +1 more
TL;DR: Patient and graft survival data from most transplantation centers has improved continously within the last decade, and the benefit for the patient is not only the salvage of life- threatening situations as in liver and heart transplantation, but also the improvement of quality of life.
Journal ArticleDOI

Validity of the detection of wheelchair propulsion as measured with an Activity Monitor in patients with spinal cord injury

TL;DR: Besides already validated other activities, wheelchair propulsion (hand-rim wheelchair propulsion and handbiking) can be validly detected by the AM in patients with SCI, both with good and poor triceps strength.
Journal ArticleDOI

Stem cell transplantation therapy for multifaceted therapeutic benefits after stroke

TL;DR: The characteristics of cell therapy in different ischemic models and the application of stem cells and progenitor cells as regenerative medicine for the treatment of stroke are discussed.
Journal Article

Guidelines on neurogenic lower urinary tract dysfunction

TL;DR: It is shown that lower urinary tract dysfunction as persistent complication of radical hysterectomy as well as pelvic floor function preand postradical prostatectomy using clinical neurourological investigations, urodynamics and electromyography using data from Anesthesiology 2001.
Related Papers (5)
Trending Questions (1)
What is the biological half-life of the kidneys?

The biological half-life of kidneys varies based on donor type, recipient race, age, cold ischemia time, and HLA mismatches, ranging from 5.4 to 26.5 years in different scenarios.